The annual Conference on Retroviruses and Opportunistic Infections (CROI 2017) took place in Seattle, USA from 13-16 February 2017.

Conference highlights

New York

When science, community and political will come together, we can end the epidemic, says New York commissioner.

Conference bulletins

Our conference bulletins are available in English, French, Italian, Portuguese, Russian and Spanish.


Unique case of PrEP failure without drug resistance reported from Amsterdam.

Hepatitis C

New HCV infections among gay men with HIV drop by half after DAA roll-out in Netherlands.

The Rakai cohort

A benign circle: how a combination of factors has reduced HIV infections in one of the hardest-hit parts of Africa.

Mental health

Better depression care could improve outcomes for HIV treatment programmes.

New HIV drug

Integrase inhibitor bictegravir matches dolutegravir for first-line HIV treatment.

HIV vaccine research

Spanish vaccine induces viral control off ART in nearly 40% of recipients.

PrEP and STIs

STI rates in PrEP users very high, but evidence that PrEP increases them is inconclusive.

aidsmap news from CROI 2017

← First123Next →

Editors' picks from other sources

Subscribe now

Sign up for our free email news bulletins

Find out more and sign up to the full range of aidsmap email bulletins >

Official conference website

Find out more on the CROI website.

Visit the conference website >

aidsmap news apps

Keep up to date with the latest HIV news using the free aidsmap news apps for android and iPhone.

Download the app >

NAM's coverage of CROI 2017 has been made possible thanks to support from Janssen and ViiV Healthcare.

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.